Applications, hearings, determinations, etc.: Johnson Matthey Inc.,


[Federal Register: September 29, 2006 (Volume 71, Number 189)]


[Page 57569-57570]

From the Federal Register Online via GPO Access []



Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Registration

By Notice dated May 9, 2006, and published in the Federal Register on May 15, 2006, (71 FR 28052), Johnson Matthey Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 08066, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedule II:



Dihydrocodeine (9120)...................... II Oxymorphone (9652)......................... II

The company plans to manufacture in bulk for distribution to its customers, who are final dosage manufacturers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Johnson Matthey Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Johnson Matthey Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical

[[Page 57570]]

security systems, verification of the company's compliance with State and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Dated: September 20, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6-16023 Filed 9-28-06; 8:45 am]